Search Results for: Aurora
Aurora Cannabis Repurchases ~$103 Million Principal Amount of Convertible Notes
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the…
Aurora Cannabis Announces Fiscal 2023 First Quarter Results
Reiterates Reaching Adjusted EBITDA Profitability by December 31, 2022 Reaffirms $150 to $170 Million in Annualized Cost Savings Achieved by December…
Aurora Cannabis Repurchases ~US$23 Million Principal Amount of Convertible Notes
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the…
Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results
Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net…
Aurora Cannabis Announces Fiscal 2022 Third Quarter Results
Increasing Original Target for Expense Savings; Management Now Expects $150 to $170 Million in Annualized Cost Savings by H1/2023…
Aurora Cannabis to Host Third Quarter Fiscal Year 2022 Investor Conference Call
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining…
Aurora Cannabis Advances Premiumization Strategy by Acquiring Thrive Cannabis, and its Award-Winning Greybeard Brand, in a Margin Accretive Transaction
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining…
Aurora Cannabis Announces Fiscal 2022 Second Quarter Results
Global Cannabis Net Revenue of $60.6 Million Adjusted EBITDA Improved by 22% to a loss of $9.0…
Aurora Cannabis to Host Second Quarter Fiscal Year 2022 Investor Conference Call
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining…
Aurora Cannabis to Host Second Quarter Fiscal Year 2022 Investor Conference Call on Feb. 10
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the…
Recent Comments